Cited by 274Telomeres, Telomerase, and SenescenceCancer-related Molecular PathwaysGenetics, Aging, and Longevity in Model Organisms

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Oncogene-Induced Senescence: Putting the Brakes on Tumor Development

Braig, Melanie, Schmitt, Clemens A.·2006·Cancer Research

DOI 10.1158/0008-5472.can-05-4006

Open this paper in CoChat — free account

Abstract

Cellular senescence, a permanent cell cycle arrest, is considered a safeguard mechanism that may prevent aged or abnormal cells from further expansion. Although the term “replicative senescence” stands for the widely accepted model of a terminal growth arrest due to telomere attrition, the significance of “oncogene-inducible senescence” remained an issue of debate over the years. A number of recent studies now show the effect of this acute and telomere-independent form of senescence as a tumor-protective, fail-safe mechanism in vivo that shares conceptual and possibly therapeutic similarities with the genetically encoded apoptosis machinery. (Cancer Res 2006; 66(6): 2881-4)

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-05-4006

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Regulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 2×
“In Ras-provoked senescent cells, retinoblastoma (Rb) protein– mediated senescence-associated heterochromatin foci have been identified as sites of local transcriptional repression, where heterochromatin proteins are recruited to E2F-responsive promoters (7).”
Background
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
Reversal of human cellular senescence: roles of the p53 and p16 pathways
Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg417 · Cited by 1,457

Show all 29 references

Sorted by citations

The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
Coppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302
“Several lines of evidence indicate that cellular senescence is a potent tumor-suppressive mechanism [4,9,10].”
Background
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J., & Kirkland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64098 · Cited by 1,774
Inflammatory networks during cellular senescence: causes and consequences.
Freund, A., Orjalo, A. V., Desprez, P.-Y., & Campisi, J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.03.003 · Cited by 1,354
Melanoma
Miller, A. J., & Mihm, M. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052166 · Cited by 1,418
The ATM–Chk2 and ATR–Chk1 Pathways in DNA Damage Signaling and Cancer
Smith, J., Tho, L. M., Xu, N., & Gillespie, D. A. (2010) · Advances in cancer research · doi:10.1016/b978-0-12-380888-2.00003-0 · Cited by 1,331
Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype
Wiley, C. D., Velarde, M. C., Lecot, P., Liu, S., Sarnoski, E. A., Freund, A., Shirakawa, K., Lim, H. W., Davis, S. S., Ramanathan, A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.11.011 · Cited by 1,275
“One consequence of mitochondrial dysfunction is cellular senescence, a complex stress response by which proliferative cells permanently lose the ability to divide (Braig and Schmitt, 2006; Campisi and d’Adda di Fagagna, 2007).”
Background
Senescent cells as a source of inflammatory factors for tumor progression
Davalos, A. R., Coppe, J.-P., Campisi, J., & Desprez, P.-Y. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9220-9 · Cited by 636
DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion
Rodier, F., Muñoz, D. P., Teachenor, R., Chu, V., Le, O., Bhaumik, D., Coppé, J.-P., Campeau, E., Beauséjour, C. M., Kim, S.-H., et al. (2011) · Journal of Cell Science · doi:10.1242/jcs.071340 · Cited by 535
p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells
Iannello, A., Thompson, T. W., Ardolino, M., Lowe, S. W., & Raulet, D. H. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130783 · Cited by 414
Recognition of Tumors by the Innate Immune System and Natural Killer Cells
Marcus, A., Gowen, B. G., Thompson, T. W., Iannello, A., Ardolino, M., Deng, W., Wang, L., Shifrin, N. T., & Raulet, D. H. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800267-4.00003-1 · Cited by 410
GUARDIN is a p53-responsive long non-coding RNA that is essential for genomic stability
Hu, W. L., Jin, L., Xu, A., Wang, Y. F., Thorne, R. F., Zhang, X. D., & Wu, M. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0066-7 · Cited by 346
Cellular senescence and the aging brain
Chinta, S. J., Woods, G., Rane, A., Demaria, M., Campisi, J., & Andersen, J. K. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2014.09.018 · Cited by 282
Senescent tumor cells lead the collective invasion in thyroid cancer
Kim, Y. H., Choi, Y. W., Lee, J., Soh, E. Y., Kim, J.-H., & Park, T. J. (2017) · Nature Communications · doi:10.1038/ncomms15208 · Cited by 253
Loss of linker histone H1 in cellular senescence
Funayama, R., Saito, M., Tanobe, H., & Ishikawa, F. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200604005 · Cited by 241
“Indeed, it was recently reported that senescent cells exist in several types of premalignant tumors in vivo and that cellular senescence is required to prevent tumorigenesis in vivo (Braig and Schmitt, 2006).”
Background
High‐throughput microRNAome analysis in human germ cell tumours
Gillis, A., Stoop, H., Hersmus, R., Oosterhuis, J. W., Sun, Y., Chen, C., Guenther, S. M., Sherlock, J. K., Veltman, I. M., Baeten, J., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2230 · Cited by 240
Tumor risk in disorders of sex development (DSD)
Looijenga, L. H. J., Hersmus, R., Oosterhuis, J. W., Cools, M., Drop, S. L. S., & Wolffenbuttel, K. P. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.05.001 · Cited by 232
Nutlin-3a Activates p53 to Both Down-regulate Inhibitor of Growth 2 and Up-regulate mir-34a, mir-34b, and mir-34c Expression, and Induce Senescence
Kumamoto, K., Spillare, E. A., Fujita, K., Horikawa, I., Yamashita, T., Appella, E., Nagashima, M., Takenoshita, S., Yokota, J., & Harris, C. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2780 · Cited by 231
Cold atmospheric plasma, a new strategy to induce senescence in melanoma cells
Arndt, S., Wacker, E., Li, Y., Shimizu, T., Thomas, H. M., Morfill, G. E., Karrer, S., Zimmermann, J. L., & Bosserhoff, A. (2013) · Experimental Dermatology · doi:10.1111/exd.12127 · Cited by 225
Tumor Risk in Disorders of Sex Development
Pleskacova, J., Hersmus, R., Oosterhuis, J. W., Setyawati, B. A., Faradz, S. M., Cools, M., Wolffenbuttel, K. P., Lebl, J., Drop, S. L. S., & Looijenga, L. H. J. (2010) · Sexual Development · doi:10.1159/000314536 · Cited by 215
Hsp70 in cancer: back to the future
Sherman, M. Y., & Gabai, V. L. (2014) · Oncogene · doi:10.1038/onc.2014.349 · Cited by 213
Senolytics and senostatics as adjuvant tumour therapy
Short, S. C., Fielder, E., Miwa, S., & von Zglinicki, T. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.056 · Cited by 207
BRAF Activation Induces Transformation and Then Senescence in Human Neural Stem Cells: A Pilocytic Astrocytoma Model
Raabe, E. H., Lim, K. S., Kim, J. M., Meeker, A. K., Mao, X., Nikkhah, G., Maciaczyk, J., Kahlert, U. D., Jain, D., Bar, E. E., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3349 · Cited by 199
FOXM1 (Forkhead box M1) in Tumorigenesis
Wierstra, I. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00016-2 · Cited by 190
The Transcription Factor FOXM1 (Forkhead box M1)
Wierstra, I. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407173-5.00004-2 · Cited by 180
PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation
Lee, J.-J., Kim, B. C., Park, M.-J., Lee, Y., Kim, Y.-N., Lee, B. L., & Js, L. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.139 · Cited by 179
Heat Shock Proteins in Cancer
Sherman, M. Y., & Multhoff, G. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1391.030 · Cited by 178
Environmental stress, ageing and glial cell senescence: a novel mechanistic link to Parkinson's disease?
Chinta, S. J., Lieu, C. A., DeMaria, M., Laberge, R. ‐., Campisi, J., & Andersen, J. K. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12029 · Cited by 165
“In addition, strong mitogenic signals such as those induced by activated oncogenes can cause the senescence response [12, 25, 26].”
Epithelial-mesenchymal transition and inflammation at the site of the primary tumor
Dominguez, C. L., David, J. M., & Palena, C. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.08.002 · Cited by 163
Multiple microRNAs rescue from Ras-induced senescence by inhibiting p21Waf1/Cip1
Borgdorff, V, Lleonart, M. E., Bishop, C. L., Fessart, D., Bergin, A. H., Overhoff, M. G., & Beach, D. H. (2010) · Oncogene · doi:10.1038/onc.2009.497 · Cited by 160
Quercetin promotes cell apoptosis and inhibits the expression of MMP-9 and fibronectin via the AKT and ERK signalling pathways in human glioma cells
Pan, H., Jiang, Q., Yu, Y., Mei, J.-P., Cui, Y., & Zhao, W. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.12.001 · Cited by 159
Cellular senescence and chromatin structure
Funayama, R., & Ishikawa, F. (2007) · Chromosoma · doi:10.1007/s00412-007-0115-7 · Cited by 153
Epstein‐Barr virus and the pathogenesis of Burkitt's lymphoma: More questions than answers
Bornkamm, G. W. (2008) · International Journal of Cancer · doi:10.1002/ijc.24223 · Cited by 156
Malignant Melanoma in the 21st Century: The Emerging Molecular Landscape
Sekulić, A., Haluska, P., Miller, A. J., Lamo, J. G. D., Ejadi, S., Pulido, J. S., Salomão, D. R., Thorland, E. C., Vile, R. G., Swanson, D. C., et al. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.7.825 · Cited by 144
Stem cells, senescence, neosis and self-renewal in cancer.
Rajaraman, R., Guernsey, D. L., Rajaraman, M. M., & Rajaraman, S. R. (2006) · Cancer Cell International · doi:10.1186/1475-2867-6-25 · Cited by 152
Resveratrol and quercetin cooperate to induce senescence‐like growth arrest in C6 rat glioma cells
Zamin, L. L., Filippi‐Chiela, E. C., Dillenburg-Pilla, P., Horn, F., Salbego, C. G., & Lenz, G. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01215.x · Cited by 146
Induction of p53-Dependent Senescence by the MDM2 Antagonist Nutlin-3a in Mouse Cells of Fibroblast Origin
Efeyan, A., Ortega-Molina, A., Velasco-Miguel, S., Herranz, D., Vassilev, L. T., & Serrano, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0200 · Cited by 140
Senescence and the tumor-immune landscape: Implications for cancer immunotherapy
Chibaya, L., Snyder, J. T., & Ruscetti, M. A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.005 · Cited by 146
Oncogene-Induced Senescence Pathways Weave an Intricate Tapestry
Yaswen, P., & Campisi, J. (2007) · Cell · doi:10.1016/j.cell.2007.01.005 · Cited by 142
Cellular Interactions in the Tumor Microenvironment: The Role of Secretome
da Cunha, B. R., Domingos, C., Stefanini, A. C. B., Henrique, T., Polachini, G. M., Castelo‐Branco, P., & Tajara, E. H. (2019) · Journal of Cancer · doi:10.7150/jca.21780 · Cited by 133
Molecular Mechanisms of Ursodeoxycholic Acid Toxicity & Side Effects: Ursodeoxycholic Acid Freezes Regeneration & Induces Hibernation Mode
Kotb, M. A. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13078882 · Cited by 117
ST6GAL1: A key player in cancer (Review)
Garnham, R., Scott, E., Livermore, K. E., & Munkley, J. (2019) · Oncology Letters · doi:10.3892/ol.2019.10458 · Cited by 114
Heat Shock Protein Hsp72 Controls Oncogene-Induced Senescence Pathways in Cancer Cells
Gabai, V. L., Yaglom, J. A., Waldman, T. A., & Sherman, M. Y. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01041-08 · Cited by 117
Role of ING4 in human melanoma cell migration, invasion and patient survival
Li, J., Martinka, M., & Li, G. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn086 · Cited by 111
Heat Shock Transcription Factor Hsf1 Is Involved in Tumor Progression via Regulation of Hypoxia-Inducible Factor 1 and RNA-Binding Protein HuR
Gabai, V. L., Le, M., Kim, G., Mills, T. A., Benjamin, I. J., & Sherman, M. Y. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05921-11 · Cited by 105
Targeting the Akt Kinase to Modulate Survival, Invasiveness and Drug Resistance of Cancer Cells
Cassinelli, G., Zuco, V., Gatti, L., Lanzi, C., Zaffaroni, N., Colombo, D., & Perego, P. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990106 · Cited by 104
Regulation of senescence and the SASP by the transcription factor C/EBPβ
Salotti, J., & Johnson, P. F. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110752 · Cited by 103
The evolving concept of tumor microenvironments
Laconi, E. (2007) · BioEssays · doi:10.1002/bies.20606 · Cited by 103
Anticancer drug discovery in the future: an evolutionary perspective
Ma, X., & Wang, Z. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.09.006 · Cited by 96
Suppression of Nonhomologous End Joining Repair by Overexpression of HMGA2
Li, A. Y. J., Boo, L. M., Wang, S., Lin, H. H., Wang, C. C. C., Yen, Y., Chen, B. P. C., Chen, D. J., & Ann, D. K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4833 · Cited by 90
From cancer immunosurveillance to cancer immunotherapy
Stagg, J., Johnstone, R. W., & Smyth, M. J. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00566.x · Cited by 91
Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence
Drullion, C., Trégoat, C., Lagarde, V, Tan, S., Gioia, R., Priault, M., Djavaheri-Mergny, M., Brisson, A., Auberger, P., Mahon, F.-X., et al. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.111 · Cited by 88
Short-term gain, long-term pain: the senescence life cycle and cancer
Chan, A. S. L., & Narita, M. (2019) · Genes & Development · doi:10.1101/gad.320937.118 · Cited by 80
Erratum to: From cell senescence to age-related diseases: differential mechanisms of action of senescence-associated secretory phenotypes
Byun, H., Lee, Y., Kim, J., & Yoon, G. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.11.122 · Cited by 81
Mitochondrial DNA damage induces apoptosis in senescent cells
Laberge, R.-M., Adler, D., DeMaria, M., Mechtouf, N., Teachenor, R., Cardin, G. B., Desprez, P.-Y., Campisi, J., & Rodier, F. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.199 · Cited by 82
Induction of Autophagy and Inhibition of Melanoma Growth In Vitro and In Vivo by Hyperactivation of Oncogenic BRAF
Maddodi, N., Huang, W., Havighurst, T., Kim, K., Jack Longley, B., & Setaluri, V. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.26 · Cited by 80
The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo
Reimann, M., Loddenkemper, C., Rudolph, C., Schildhauer, I., Teichmann, B., Stein, H., Schlegelberger, B., Dörken, B., & Schmitt, C. A. (2007) · Blood · doi:10.1182/blood-2007-02-075614 · Cited by 82
Self-citation
NF-κB-dependent cytokine secretion controls Fas expression on chemotherapy-induced premature senescent tumor cells
Crescenzi, E., Pacifico, F., Lavorgna, A., Palma, R. D., D’Aiuto, E., Palumbo, G. A., Formisano, S., & Leonardi, A. (2011) · Oncogene · doi:10.1038/onc.2011.1 · Cited by 76
Ras-Induced Senescence and its Physiological Relevance in Cancer
DiMauro, T., & David, G. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910793357998 · Cited by 77
Therapeutic targeting of replicative immortality
Yaswen, P., MacKenzie, K. L., Keith, W. N., Hentosh, P., Rodier, F., Zhu, J., Firestone, G. L., Matheu, A., Carnero, A., Bilsland, A. E., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.007 · Cited by 82
Markers of cellular senescence.
Carnero, A. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_4 · Cited by 68
The EBNA3 Family: Two Oncoproteins and a Tumour Suppressor that Are Central to the Biology of EBV in B Cells
Allday, M. J., Bazot, Q., & White, R. E. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22834-1_3 · Cited by 71
Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions
Vazquez-Martin, A., López-Bonetc, E., Cufí, S., Oliveras-Ferraros, C., Del Barco, S., Martin-Castillo, B., & Menendez, J. A. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.04.003 · Cited by 66
Conditional Deletion of Insulin-like Growth Factor-I Receptor in Prostate Epithelium
Sutherland, B. W., Knoblaugh, S. E., Kaplan‐Lefko, P. J., Wang, F., Holzenberger, M., & Greenberg, N. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6531 · Cited by 66
Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future implications
Zhao, B., Wu, B. C., Feng, N., Zhang, X., Zhang, X., Wei, Y., & Zhang, W. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01426-4 · Cited by 68
Epstein–Barr virus and its role in the pathogenesis of Burkitt's lymphoma: An unresolved issue
Bornkamm, G. W. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.07.002 · Cited by 64
G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer
Cheriyath, V., Kuhns, M. A., Jacobs, B., Evangelista, P. J., Elson, P. J., Downs-Kelly, E. P., Tubbs, R., & Borden, E. C. (2011) · Oncogene · doi:10.1038/onc.2011.393 · Cited by 64
Chromatin unfolding by Cdt1 regulates MCM loading via opposing functions of HBO1 and HDAC11-geminin
Wong, P. G., Glozak, M. A., Cao, T. V., Vaziri, C., Seto, E., & Alexandrow, M. G. (2010) · Cell Cycle · doi:10.4161/cc.9.21.13596 · Cited by 64
Re-expression of ABI3-binding protein suppresses thyroid tumor growth by promoting senescence and inhibiting invasion
Latini, F. R., Hemerly, J. P., Oler, G., Riggins, G. J., & Cerutti, J. M. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0079 · Cited by 62
CPEB1, a histone-modified hypomethylated gene, is regulated by miR-101 and involved in cell senescence in glioma
Xiaoping, L., Zhibin, Y., Wenjuan, L., Zeyou, W., Gang, X., Zhaohui, L., Ying, Z., Minghua, W., & Guiyuan, L. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.197 · Cited by 61
Senescence and cancer: An evolving inflammatory paradox
Ruhland, M. K., Coussens, L. M., & Stewart, S. A. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.10.001 · Cited by 62
HSP70s in Breast Cancer: Promoters of Tumorigenesis and Potential Targets/Tools for Therapy
Kabakov, A. E., & Gabai, V. L. (2021) · Cells · doi:10.3390/cells10123446 · Cited by 55
Immune Surveillance of Unhealthy Cells by Natural Killer CellsPreprint
Iannello, A., & Raulet, D. H. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020255 · Cited by 60
Glucose metabolism and hexosamine pathway regulate oncogene-induced senescence
Gitenay, D., Wiel, C., Lallet-Daher, H., Vindrieux, D., Aubert, S., Payen, L. F., Simonnet, H., & Bernard, D. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.63 · Cited by 54
Nutlins and Ionizing Radiation in Cancer Therapy
Impicciatore, G. G., Sancilio, S., Miscia, S., & Pietro, R. D. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791033932 · Cited by 50
Tip60: updates
Ghobashi, A. H., & Kamel, M. A. E.-N. (2018) · Journal of Applied Genetics · doi:10.1007/s13353-018-0432-y · Cited by 47
Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells
Arthan, D., Hong, S., & Park, J. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.04.021 · Cited by 46
Large cell change of hepatocytes in chronic viral hepatitis represents a senescent-related lesion
Ikeda, H., Sasaki, M., Sato, Y., Harada, K., Zen, Y., Mitsui, T., & Nakanuma, Y. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.06.009 · Cited by 44
Cellular senescence in cancer: molecular mechanisms and therapeutic targets
Jin, P., Duan, X., Li, L., Zhou, P., Zou, C., & Xie, K. (2024) · MedComm · doi:10.1002/mco2.542 · Cited by 51
Cellular Senescence as a Target in Cancer Control
Vergel, M., Marín, J., Estévez, P., & Carnero, A. (2010) · Journal of Aging Research · doi:10.4061/2011/725365 · Cited by 45
Occludin‐mediated premature senescence is a fail‐safe mechanism against tumorigenesis in breast carcinoma cells
Osanai, M., Murata, M., Nishikiori, N., Chiba, H., Kojima, T., & Sawada, N. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00494.x · Cited by 46
Spatial resolution of cellular senescence dynamics in human colorectal liver metastasis
Garbarino, O., Lambroia, L., Basso, G., Marrella, V., Franceschini, B., Soldani, C., Pasqualini, F., Giuliano, D., Costa, G., Peano, C., et al. (2023) · Aging Cell · doi:10.1111/acel.13853 · Cited by 43
“We then reasoned that c- Myc was a proto- oncogene that was not only involved in ribosome biogenesis; indeed, activated oncogenes are prominent inducers of senescence (Braig & Schmitt, 2006).”
Background
Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells
Le, H. H., Çınaroğlu, S. S., Manalo, E. C., Ors, A., Gomes, M. M., Sahbaz, B. D., Bonic, K., Marmolejo, C. A. O., Quentel, A., Plaut, J. S., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103646 · Cited by 44
Targeting the p53 Pathway in Ewing Sarcoma
Neilsen, P. M., Pishas, K. I., Callen, D. F., & Thomas, D. M. (2010) · Sarcoma · doi:10.1155/2011/746939 · Cited by 43
RANK links senescence to stemness in the mammary epithelia, delaying tumor onset but increasing tumor aggressiveness
Benítez, S., Cordero, A., Santamaría, P. G., Redondo-Pedraza, J., Rocha, A. S., Collado-Solé, A., Jimenez, M., Sanz-Moreno, A., Yoldi, G., Santos, J. C., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.04.022 · Cited by 41
Sensitization of cervix cancer cells to Adriamycin by Pentoxifylline induces an increase in apoptosis and decrease senescence
Bravo‐Cuéllar, A., Ortiz‐Lazareno, P. C., Lerma-Díaz, J. M., Domínguez-Rodríguez, J. R., Jave‐Suárez, L. F., Aguilar‐Lemarroy, A., del Toro‐Arreola, S., Célis, R. D., Sahagún-Flores, J. E., de Alba-García, J. E. G., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-114 · Cited by 41
Immunosurveillance of senescent cancer cells by natural killer cells
Iannello, A., & Raulet, D. H. (2014) · OncoImmunology · doi:10.4161/onci.27616 · Cited by 41
Genetic cooperation between p21Cip1 and INK4 inhibitors in cellular senescence and tumor suppression
Quereda, V., Martinalbo, J., Dubus, P. R., Carnero, A., & Malumbres, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210578 · Cited by 41
Overexpression of the DEC1 Protein Induces Senescence In Vitro and Is Related to Better Survival in Esophageal Squamous Cell Carcinoma
Xu, Q., Ma, P., Hu, C., Chen, L., Xue, L., Wang, Z., Liu, M., Zhu, H., Xu, N., & Lü, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041862 · Cited by 40
Silencing Nuclear Pore Protein Tpr Elicits a Senescent-Like Phenotype in Cancer Cells
David‐Watine, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022423 · Cited by 39
Parity-induced changes to mammary epithelial cells control NKT cell expansion and mammary oncogenesis
Somasundara, A. V. H., Moss, M. A., Feigman, M. J., Chen, C., Cyrill, S. L., Ciccone, M. F., Trousdell, M. C., Vollbrecht, M., Li, S., Kendall, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110099 · Cited by 36
Senescence‐associated β‐galactosidase activity marks the visceral endoderm of mouse embryos but is not indicative of senescence
Huang, T., & Rivera‐Pérez, J. A. (2014) · genesis · doi:10.1002/dvg.22761 · Cited by 38
p35 Is Required for CDK5 Activation in Cellular Senescence
Mao, D., & Hinds, P. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.066118 · Cited by 39
A ‘telomere-associated secretory phenotype’ cooperates with BCR-ABL to drive malignant proliferation of leukemic cells
Braig, M., Pällmann, N., Preukschas, M., Steinemann, D., Hofmann, W. A., Gompf, A., Streichert, T., Braunschweig, T. A., Copland, M., Rudolph, K. L., et al. (2014) · Leukemia · doi:10.1038/leu.2014.95 · Cited by 36
Self-citation
Disruptive chemicals, senescence and immortality
Carnero, A., Blanco‐Aparicio, C., Kondoh, H., LLeonart, M. E., Martínez-Leal, J. F., Mondello, C., Scovassi, A. I., Bisson, W. H., Amedei, A., Roy, R., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv029 · Cited by 36
MicroRNAs Regulate Key Effector Pathways of Senescence
Feliciano, A., Sánchez‐Sendra, B., Kondoh, H., & LLeonart, M. E. (2011) · Journal of Aging Research · doi:10.4061/2011/205378 · Cited by 34
Cellular senescence offers distinct immunological vulnerabilities in cancer
Zhou, L., Ma, B., & Ruscetti, M. A. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.11.010 · Cited by 40
Strategies for Overcoming Resistance in Tumours Harboring BRAF Mutations
Obaid, N., Bedard, K., & Huang, W. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030585 · Cited by 37

Authors: Braig, M., & Schmitt, C. A.
Affiliations: Charité – Universitätsmedizin Berlin (DE)
Max Delbrück Center (DE)
ORCID: Schmitt, Clemens A.
Venue: Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2006-03-15
Volume: 66
Issue: 6
Pages: 2881-2884
ISSN: 0008-5472 (ISSN-L)
1538-7445
DOI: 10.1158/0008-5472.can-05-4006
OpenAlex: W2044729521
Cited by: 274
References: 29
Citations by year: 2026: 6 · 2025: 5 · 2024: 7 · 2023: 14 · 2022: 13 · 2021: 9 · 2020: 8 · 2019: 9 · 2018: 7 · 2017: 10 · 2016: 11 · 2015: 13 · 2014: 23 · 2013: 22 · 2012: 19
FWCI: 12.08
Type: journal article
Language: en
Open access: closed
Locations: Cancer Research (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords: oncogene-induced senescence, cellular senescence, replicative senescence, telomere shortening, tumor suppression, cell cycle arrest, apoptosis, cancer therapy
MeSH terms: Animals, Cell Transformation, Neoplastic, Humans, Oncogenes, Precancerous Conditions, Cellular Senescence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Oncogene-Induced Senescence: Putting the Brakes on Tumor Development

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks